NCT04796142

Medication Reconciliation in Oncologic Patients

An Integrated Model to Increase Medication Recognition and Reconciliation in Oncologic Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To improve medication reconciliation in oncologic patients in healthcare transitions through an alliance between a Cancer Institute and the community pharmacies and a new integrated IT platform.

Detailed description

This trial will explore the alliance between a Cancer Institute and the community pharmacies to improve medication reconciliation in healthcare transitions, and will validate a new integrated IT platform. Cancer patients receiving an oncologic treatment will be asked to choose a pharmacy participating to the trial, and to perform the pharmacological survey before every cycle of chemotherapy. This will be sent through the new IT platform to the electronic medical record of IRST, and the Oncologist will perform the reconciliation. Data about concomitant medications and possible interactions will be exensively analyzed.

Conditions

• Medication Reconciliation

Interventions

Type	Name	Description
OTHER	medication reconciliation	medication reconciliation

Timeline

• Start date: 2019-06-12
• Primary completion: 2023-06-15
• Completion: 2023-09-15
• First posted: 2021-03-12
• Last updated: 2024-12-09

Locations

1 site across 1 country: Italy